From: Development and validation of a questionnaire to assess delay in treatment for breast cancer
Mean (SD, range) | ||
---|---|---|
Dimensions | Test 1 | Test 2 |
Total questionnaire score | 30 (8.48, 12–44) | 27 (8.65, 11–41) |
1. Means of problem identification | 1 (0.38, 0–1) | 1 (0.41, 0–1) |
2. First symptom identified by the patient | 1 (0.51, 0–1) | 0 (0.51, 0–1) |
3. Patient initial interpretations of symptoms | 4 (2.35, 1–8) | 4 (2.31, 1–8) |
4. Breast cancer symptoms present at arrival to the cancer hospital | 2 (1.66, 0–6) | 2 (1.52, 0–5) |
5. Most worrisome symptom for the patient | 0 (0.51, 0–1) | 0 (0.49, 0–1) |
6. Patient’s reason for seeking medical care | 1 (0.44, 0–1) | 1 (0.51, 0–1) |
7. Patient’s perception of patient delay | 2 (1.65, 0–3) | 2 (1.21, 0–3) |
8. Patient’s perceived reasons for patient delay | 4 (2.45, 0–8) | 3 (2.65, 0–9) |
9. Patient’s perceived barriers to have caused provider delay | NA | NA |
10. Health service utilization | 6 (2.27, 1–10) | 5 (2.31, 1–9) |
11. Social network support for medical attention | 5 (0.50, 4–5) | 5 (0.51, 4–5) |
12. Time between problem identification and talking to someone | 0 (0.41, 0–1) | 0 (0.42, 0–1) |
13. Use of alternative medicine | 1 (0.41, 0–1) | 0 (0.18, 0–1) |
14. Cancer-related knowledge | 3 (1.11, 0–5) | 3 (1.09, 1–5) |
15. Cancer screening practices | 2 (1.22, 0–5) | 2 (1.43, 0–5) |